Skip to main content
IBEX TECHNOLOGIES INC. logo

IBEX TECHNOLOGIES INC. — Investor Relations & Filings

Ticker · IBT ISIN · CA4489375085 TSXV Manufacturing
Filings indexed 148 across all filing types
Latest filing 2024-05-24 Regulatory Filings
Country CA Canada
Listing TSXV IBT

About IBEX TECHNOLOGIES INC.

http://ibex-tech.com/

IBEX Technologies Inc. develops, manufactures, and markets high-purity enzymes and specialized reagents for biomedical use. The company's product portfolio includes a family of proprietary enzymes utilized in pharmaceutical research, notably for applications in arthritis and oncology, and diagnostic products. IBEX serves the In Vitro Diagnostics (IVD) sector and general research markets by supplying essential raw materials.

Recent filings

Filing Released Lang Actions
Decision Document / Order for Application - French.pdf
Regulatory Filings Classification · 95% confidence The document is a formal decision from Canadian securities regulatory authorities regarding the revocation of the status of a reporting issuer for TECHNOLOGIES IBEX INC. It references specific securities regulations and rules in Quebec and Ontario, and details the conditions under which the issuer's status is revoked. The document is a regulatory decision notice, not a financial report, earnings release, or management discussion. It does not contain financial statements or analysis but is a regulatory filing related to securities law compliance and issuer status. The document length is under 5,000 characters and is a formal decision notice, fitting the Regulatory Filings (RNS) category as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-05-24 English
Notice.pdf
Regulatory Filings
2024-04-10 English
Other material contracts - English.pdf
Regulatory Filings
2024-04-09 English
Material change report - English.pdf
Delisting Announcement Classification · 95% confidence The document is titled 'Form 51-102F3 Material Change Report' and details a significant corporate event: the sale of IBEX Technologies Inc. to BBI Solutions OEM Limited, including shareholder approval and plans for delisting from the TSX Venture Exchange. The content focuses on the announcement of this material change, including transaction details and regulatory steps such as delisting and cessation of reporting issuer status. The document length is 2028 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. There are no financial statements or detailed financial analysis present, indicating this is not an Annual Report, Interim Report, or similar. The key event is the sale and impending delisting, which aligns with the definition of a Delisting Announcement (DLST). Therefore, the document should be classified as a Delisting Announcement (DLST).
2024-04-08 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a short memorandum from the CFO/Director notifying about an amended filing of the company's quarterly financial statements due to missing pages in the initial filing. It does not contain the financial statements themselves but is an announcement regarding the filing correction. The document length is only 580 characters, indicating it is a brief notice rather than a full report. According to the 'MENU VS MEAL' rule, such a short notice about a filing correction should be classified as a Regulatory Filing (RNS), not as the actual Interim/Quarterly Report (IR).
2024-04-08 English
News release - English.pdf
Delisting Announcement Classification · 95% confidence The document announces the completion of the sale of IBEX Technologies Inc. through amalgamation with a subsidiary of BBI Solutions OEM Limited. It details the transaction price, shareholder approval, and the company's application for delisting from the TSX Venture Exchange. There are no financial statements or detailed financial performance data included. The document is a corporate announcement about a transaction and delisting, not a full report or financial filing. Therefore, it fits best under the 'Delisting Announcement' category (DLST). The document length is 3223 characters, which is consistent with an announcement rather than a full report.
2024-04-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.